Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • InflaRx to Present at the Raymond James Human Health Innovation Conference
    www.inflarx.de
  • Avisa Diagnostics to Participate in Renmark’s Virtual Non-Deal Roadshow Series on June 17, 2021
    www.avisapharma.com
  • Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19
    www.relieftherapeutics.com
  • ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions
    www.adocia.com
  • InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab
    www.inflarx.de
  • Avisa Diagnostics Appoints Barbara Bunger, PhD as Vice President, Clinical Development
    www.avisapharma.com
  • Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration
    www.relieftherapeutics.com
  • ADOCIA presents clinical results on M1Pram at the 14th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2021)
    www.adocia.com
  • ADOCIA Reinforces Its Board of Directors with the Appointment of Three New Independent Members
    www.adocia.com
  • APEIRON Biologics Announces Changes to Management and Supervisory Boards
    www.apeiron-biologics.com